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The flux of calcium ions (Ca 2+) into the cytosol, where they 
serve as intracellular messengers, is regulated by two distinct 
families of Ca 2+ channel proteins. These are the intracellular 
Ca 2+ release channels, which allow Ca 2+ to enter the cytosol from 
intracellular stores, and the plasma membrane Ca 2+ channels, 
which control Ca 2+ entry from the extracellnlar space. Each of 
these two families of channel proteins contains several subgroups. 
The intracellular channels include the large Ca 2+ channels ("ry- 
anodine receptors") that participate in cardiac and skeletal 
muscle excitation-contraction coupling, and smaller inositol 
trisphosphate (InsP3)-activated Ca 2÷ channels. The latter serve 
several functions, including the pharmacomechanical coupling 
that activates mooth muscle contraction, and possibly regulation 
of diastolic tone in the heart. The InsP3-activated Ca 2+ channels 
may also participate in signal transduction systems that regulate 
cell growth. The family of plasma membrane Ca 2+ channels 
includes L-type channels, which respond to membrane depolar- 
ization by generating a signal that opens the intraceilnlar Ca 2+ 
release channels. Calcium ion entry through L-type Ca 2+ chan- 
nels in the siuoatrial (SA) node contributes to pacemaker activity, 
whereas L-type Ca 2+ channels in the atrioventricular (AV) node 
are essential for AV conduction. The T-type Ca 2+ channels, 
another member of the family of plasma membrane Ca 2÷ chan- 
nels, participate in pharmacomechanical coupling in smooth 
muscle. Opening of these channels in response to membrane 
depolarization participates in SA node pacemaker currents, but 
their role in the working cells of the atria and ventricle is less 
clear. Like the InsP3-activated intraceilular Ca 2+ release chan- 
nels, T-type plasma membrane channels may regulate cell growth. 
Because most of the familiar Ca 2+ channel blocking agents 
currently used in cardiology, such as nifedipine, verapamil and 
diltiazem, are selective for L-type Ca 2+ channels, the recent 
development of drugs that selectively block T-type Ca 2+ channels 
offers promise of new approaches to cardiovascular therapy. 
(J Am Coll Cardiol 1996;28:522-9) 
Calcium ions (Ca2+), which can be viewed as the most 
important of nature's ignal transducers, participate in excita- 
tion and contraction of cardiac and vascular smooth muscle 
(for review see ref. 1-3). This critical signaling role reflects 
both the electric and chemical properties of Ca 2+. Because it is 
a cation, Ca 2+ carries an electric charge when it crosses the 
high resistance plasma membrane that separates the extracel- 
lular and intracellular spaces. As a result, Ca 2+ generates 
depolarizing electric currents when it enters the negatively 
charged cytosol of cells at rest. The participation of Ca 2+ in 
chemical signaling is made possible by its ability to bind tightly, 
and with considerable specificity, to high affinity Ca2+-binding 
sites on specialized proteins within the cell. 
The passage of Ca 2+ from the extracellular space into the 
cell interior is made possible by the opening of members of an 
extended family of ion-selective channels, which allows this ion 
to diffuse passively across the plasma membrane. The driving 
force for this downhill process is a large electrochemical 
gradient, which reflects the fact that extracellular Ca 2+ con- 
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centration is in the millimolar ange, whereas cytosolic Ca 2+ 
concentration i  most cells at rest is about 10,000 times lower, 
less than 1 ~mol/liter. This Ca 2+ concentration gradient, along 
with the electrical gradient hat favors Ca 2+ fluxes into the 
negatively charged cell interior, provides a powerful electro- 
chemical force that drives Ca 2+ through the open plasma 
membrane channels. 
The present review focuses on a newly recognized iversity 
in the plasma membrane Ca 2+ channels that participate in 
signal transduction in the cardiovascular system. Different 
responses of the various classes of Ca 2+ channels to newly 
discovered Ca 2+ channel blocking drugs offer novel mecha- 
nisms for the treatment of cardiovascular disease. 
Ext race l lu la r  and  In t race l lu la r  
Ca lc ium Cyc les  
Two distinct Ca 2+ cycles, both of which control the entry 
and removal of Ca 2÷ from the cytosol, can participate in cell 
signaling (Fig. 1). The most primitive is the extracellular cycle, 
in which Ca 2÷ enters and leaves the cytosol by crossing the 
plasma membrane from what is, in effect, an unlimited store of 
Ca 2+ in the extracellular space. A second Ca 2+ cycle is seen in 
more specialized cells, such as adult cardiac myocytes, where 
Ca 2÷ is pumped into and out of limited stores contained within 
an intracellular membrane system. The latter, called the sar- 
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Figure 1. Schematic diagram showing (top) key structures and (bot- 
tom) major calcium ion (Ca 2+) fluxes involved in cardiac excitation- 
contraction coupling in adult cardiac myocytes. The thickness of the 
arrows indicates the magnitude of the Ca 2+ fluxes; their direction 
describes the "energetics" of the Ca 2+ fluxes (downward arrows 
describe passive Ca ~+ fluxes, and upward arrows describe energy- 
dependent Ca 2+ transport). Ca 2+ enters the cell from the extracellular 
fluid by way of plasma membrane (plasmalemmal) Ca 2+ channels (A); 
although most of this Ca 2+ triggers calcium release from the sarco- 
plasmic reticulum, a small portion directly activates the contractile 
proteins (AI). Ca 2+ transport back into the extracellular fluid involves 
two plasma membrane systems: Na+/Ca 2+ exchange (B1) and the 
plasmalemmal Ca 2+ pump (B2). The sarcoplasmic reticulum mem- 
brane regulates two Ca 2+ fluxes: Ca "+ release from the subsarcolem- 
mal cisternae by way of the intracellular Ca 2+ release channels 
("ryanodine receptors") (C) and active Ca 2- uptake by the Ca 2+ pump 
of the sarcotubular network (D). Ca 2+ diffuses within the sarcoplasmic 
reticulum in a third Ca 2+ flux (G), returning to the subsarcolemmal 
cisternae, where it is stored in complex with calsequestrin and other 
Ca2+-binding proteins. Binding of Ca 2+ to (E) and release of Ca 2+ 
from (F) the high affinity calcium-binding sites of troponin C define its 
affinity for Ca 2+. Movements of Ca 2+ into and out of mitochondria (H) 
buffer cytosolic Ca 2- concentration. Modified from Katz (1) with 
permission. 
coplasmic reticulum in muscle cells, is a specialization of the 
endoplasmic reticulum--hence, the generic term sarco(endo)- 
plasmic reticulum. Essential to both Ca 2+ cycles, as already 
pointed out, is a Ca2+-impermeable m mbrane that contains 
both the Ca 2+ channels through which Ca 2+ diffuses into the 
cytosol, and the Ca 2+ pumps and exchangers that actively 
transport his cation uphill, back into the extracellular space 
and the lumen of the sarcoplasmic reticulum. 
The membrane proteins that actively transport Ca 2+ out of 
the cytosol include the adenosine triphosphate (ATP)- 
dependent Ca 2+ pumps in the plasma membrane and sarco- 
(endo)plasmic reticulum. These are closely related members of 
a single family of adenosine triphosphatases that also includes 
the Na + pump (Na+/K+-adenosine triphosphatase). The Na+/ 
Ca 2+ exchanger, which uses the large Na + gradient across the 
plasma membrane to transport intracellular Ca 2+ uphill out of 
the cytosol in exchange for extracellular Na +, belongs to an 
additional family of membrane proteins. 
The Ca 2+ channels in the sarco(endo)plasmic reticulum 
and plasma membrane belong to two distinct protein families 
(Table 1). The intracellular Ca 2+ release channels in the 
sarco(endo)plasmic reticulum, which can be seen as electron- 
dense structures called "feet," are large proteins that project 
into the cytosol between the sarcoplasmic reticulum and 
plasma membrane. Some intracellular Ca 2+ channels are 
referred to as ryanodine receptors because they bind to this 
plant alkaloid; others, which bind to and are activated by 
inositol trisphosphate (InsP3), are called InsP 3 receptors. The 
latter, which are opened by signaling cascades initiated by such 
extracellular messengers as alpha-adrenergic agonists and an- 
giotensin II, rather than membrane depolarization, are not 
abundant in adult working cardiac myocytes. One class of the 
smaller plasma membrane Ca 2+ channels, the L-type channels 
(see later), are sometimes called dihydropyridine receptors 
because of their high affinity binding to this class of Ca 2+ 
channel blockers. 
Coup l ing  of  the Act ion Potent ia l  to Ca z÷ 
Release in Cardiac and Skeletal  Musc le  
All muscle cells recognize a rise in cytosolic Ca 2+ concen- 
tration as a signal to contract, but the source of this activator 
Ca 2+ differs among various muscle types. In more primitive 
myocytes, uch as are found in vascular smooth muscle and the 
embryonic heart, contraction depends on Ca 2+ that enters the 
cytosol from the extracellular space (the extracellular Ca 2+ 
cycle). In contrast, the highly specialized myocytes of skeletal 
muscle and the adult heart derive most of their activator Ca 2+ 
from intracellular stores in the sarcoplasmic reticulum (the 
intracellular Ca 2+ cycle). Dependence on Ca 2+ release from 
intracellular stores requires a functional link between depolar- 
ization of the plasma membrane (the action potential) and the 
opening of intracellular Ca 2+ release channels in the sarco- 
plasmic reticulum. In skeletal muscle this link is effected by a 
mechanical coupling, in which plasma membrane depolariza- 
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Table 1. Major Calcium Channels inMuscle 
Channel Type Location Opened By Major Function 
Intracellular Ca 2+ release channels 
Ryanodine receptors 
Inositol trisphosphate receptors 
Plasma membrane Ca 2+ channels* 
L-type (dihydropyridine r ceptors) 
T-type 
Skeletal muscle 
Cardiac muscle 
Smooth muscle 
L-type Ca ~+ channel "plug" 
L-type Ca 2+ channel Ca 2+ entry 
Inositol trisphosphate 
Cardiac muscle lnositol trisphosphate 
Smooth muscle 
Skeletal muscle 
Cardiac muscle 
Atria, ventricles 
SA node 
AV node 
Smooth muscle 
Cardiac muscle 
Atria, ventricles 
SA node 
Plasma membrane depolarization 
Plasma membrane depolarization 
Plasma membrane depolarization 
Various stimuli 
Plasma membrane depolarization 
Intracellular Ca 2+ cycle 
Excitation-contraction coupling 
Excitation-contraction coupling 
Pharmacomechanical coupling 
? Growth regulation 
? Diastolic tension 
? Growth regulation 
Extracellular Ca 2+ cycle 
Excitation-contraction coupling 
Opens intracellular Ca 2+ channel 
CaX+-induced Ca 2- release 
Pacemaker activity 
AV conduction 
Pharmacomechanical coupling 
? Growth regulation 
? Growth regulation 
Pacemaker activity 
*See also Table 2. AV = atrioventricular; Ca z+ = calcium ion; SA = sinoatrial. 
tion removes a "plug" that, in the muscle at rest, occludes the 
intracellular Ca 2+ release channel. The plug itself is a portion 
of an L-type plasma membrane Ca 2+ channel (see later) that 
opens and closes the Ca 2+ release channel in the sarcoplasmic 
reticulum in response to changes in the electric potential 
across the plasma membrane. A different member of the family 
of L-type plasma membrane Ca 2+ channels couples a change 
in membrane potential to Ca 2+ release from the cardiac 
sarcoplasmic reticulum. In the heart, the action potential 
initiates contraction when the opening of a limited number of 
plasma membrane L-type Ca 2+ channels results in localized 
increases in cytosolic Ca 2+ concentration, called "Ca z+ 
sparks" (4). The latter cause a much greater Ca 2+ release from 
the sarcoplasmic reticulum by opening adjacent intracellular 
Ca 2+ release channels in a process often referred to as 
"CaZ+-induced Ca 2+ release" (5,6). 
Intracel lu lar  Ca 2+ Release Channels  
Intracellular Ca 2+ release channels, whose structure differs 
considerably from that of the Ca z+ channels in the plasma 
membrane, are members of a single family that includes at 
least wo classes of related proteins (Table 1, for review see ref. 
7-10). The ryanodine receptor Ca 2+ channels, which predom- 
inate in skeletal and cardiac muscle, deliver the large amount 
of Ca 2+ that mediates the final step in excitation-contraction 
coupling. The InsP 3 receptor intracellular Ca 2+ release chan- 
nels, which bind to and are opened by InsP3, play a major ole 
in delivering the activator Ca 2+ that initiates mooth muscle 
contraction. Because InsP3 is generated by signal transduction 
systems that are activated by such chemical mediators as 
alpha-adrenergic agonists and angiotensin II, this process is 
called pharmacomechanical coupling. As noted later, the 
InsP3-gated Ca 2+ channels often participate insignal transduc- 
tion systems other than those that activate muscle contraction. 
Both the ryanodine receptors and InsP 3 receptors are 
tetrameric structures, each subunit of which includes a large 
cytosolic domain and two alpha-helical transrnembrane seg- 
ments. The ryanodine receptors of cardiac muscle are slightly 
smaller than those of skeletal muscle, and there is only -66% 
identity between the amino acid sequences of these proteins. 
Although the InsP 3 receptors are only about half the size of the 
ryanodine receptors, there is considerable homology between 
these two classes of intracellular Ca 2+ release channel. Their 
three-dimensional structures are quite similar in that the four 
subunits in both ryanodine receptors and InsP 3 receptors are 
believed to surround a central pore through which activator 
Ca 2+ is released when the channel is opened. 
The InsP 3 receptors, whose single-channel conductance is 
less than that of the larger ryanodine receptors (11), are the 
predominant Ca 2. channels that initiate the slow contractile 
responses in smooth muscle (12). The more explosive contrac- 
tile responses of cardiac and skeletal muscle are initiated by 
the opening of the higher conductance ryanodine receptors. 
Although the function of the small numbers of InsP3-regulated 
Ca 2+ channels found in the heart is not clearly understood, 
evidence that they slowly release only a small amount of Ca 2+ 
suggests that they do not participate in the Ca 2+ cycles that 
trigger excitation-contraction coupling. They may, instead, 
participate in the regulation of rest tension (diastolic "tone"). 
An intriguing possibility is that the InsP 3 receptors, like the 
T-type Ca 2+ channels discussed later, also regulate cell growth. 
This hypothesis supported by evidence that InsP3, along with 
other inositol phosphates, participates in a number of signaling 
cascades, including some that are activated when tyrosine 
kinase-linked receptors bind to a variety of growth factors and 
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Table 2. Plasma Membrane Ion Channels That Participate in 
Electrical Signaling (the action potential) 
Channel Type Major Function 
Na + Action potential upstroke 
Ca z- Action potential p ateau (cardiac muscle) 
Pacemaker activi~, (cardiac muscle) 
K + Repolarization 
CI Repolarization 
Ca 2+ = calcium ion; CI chloride ion; K + = potassium ion; Na + - 
sodium ion. 
cytokines. Because the InsP3-regulated Ca 2+ channels are 
opened by signaling cascades that activate nuclear transcrip- 
tion factors, this class of intracellular Ca 2+ release channels 
may play an important role in regulating cell growth, differen- 
tiation and perhaps programmed cell death (apoptosis). 
Plasma Membrane Ion Channels 
The ion-selective channels in the plasma membrane, which 
are generally named for the ions that they carry (Table 2), are 
complex proteins made up of as many as five subunits, called 
alpha 1, alpha2, beta, gamma and delta (for reviews, see ref. 
13-17). Central to their physiologic function are the large 
proteins (called alpha or alpha1 subunits in different channels) 
that make up and surround the channel pore (Fig. 2). These 
subunits, which probably arose from a single primitive ancestor 
through gene duplication and divergence, determine ion spec- 
ificity and contain both the activation and inactivation gates 
that allow changes in membrane voltage to open, close and 
inactivate the channels. The alpha and alpha 1 subunits of 
plasma membrane channels, like the major proteins in the 
intracellular Ca e+ release channels, are tetramers. However, 
their structures differ considerably. Unlike the four protein 
subunits that make up the intracellular Ca e+ channels, which 
contain two alpha-helical transmembrane s gments (see ear- 
lier), each of the four domains in the alpha or alpha1 subunits 
of most plasma membrane ion channels contains six alpha- 
helical transmembrane segments (Fig. 2). Moreover, the 
N-terminal regions of the intracellular Ca z+ release channels, 
which project into the cytosol as electronmicroscopically visible 
"feet," are much larger than the N-terminal regions of the 
plasma membrane channels. 
The four domains of the alpha and alpha 1 subunits of most 
plasma membrane Na + and Ca e+ channels are encoded by a 
single gene, as are adjacent regions of a single large membrane 
protein (Fig. 3). In contrast, the four domains in most K + 
channels are encoded by separate genes and so not linked 
covalently, which allows exchanges among these domains to 
provide for a large number of channel subtypes. In some K + 
channels, the major subunits are smaller peptides that consist 
of only a portion of the ancestral channel domain (18,19). 
A number of homologies are found among the plasma 
membrane ion channels, notably in the S 4 alpha-helical trans- 
membrane segment, which is rich in charged amino acids and 
I II III IV 
c C 
~tassium conductance channel 
Figure 2. Four members of the family of ion channel proteins. The 
major subunits of the calcium (Ca 2+) and sodium (Na ÷) conductance 
channels are tetramers made up of our four covalently linked domains 
numbered I to IV. The voltage sensor that initiates contraction in 
depolarized mammalian skeletal muscle resembles the Ca 2+ channel, 
but it is smaller because it lacks a portion of the C-terminal amino acid 
sequence of the latter. Potassium (K+) conductance channels also 
contain four domains, but unlike the domains of the Ca 2+ and Na + 
channels, domains I to IV of the K- channels are not covalently linked 
through a continuous peptide chain. C = carbon terminal; N = 
nitrogen terminal. Modified from Katz (1) with permission. 
so serves as the "voltage sensor" that mediates the voltage- 
dependent conformational change that activates the channel. 
Other homologies among the plasma membrane ion channels 
are found in the "pore" region, which is made up of the $5 and 
Figure 3. An ion channel domain. The ion channels depicted in Figure 
2 are tetramers made up of four domains, each of which contains ix 
alpha-helical transmembrane segments. Known ion channel domains 
are believed to have evolved from a common ancestral protein. The $4 
segment, which is rich in positively charged amino acids, is believed to 
open the channel in response to membrane depolarization. The 
transmembrane segments $5 and $6, along with the intervening peptide 
chain, probably surround the pore through which ions cross the lipid 
barrier in the core of the membrane bilayer. C - carbon terminal; N = 
nitrogen terminal. Adapted from Katz AM, N Engl J Med 1993;328: 
1244-51. Copyright 1993. Massachusetts Medical Society. All rights 
reserved. 
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$6 alpha-helical transmembrane s gments and intervening 
sequence of amino acids. 
The pore region in these ion channels is of considerable 
pharmacologic interest because variations among the amino 
acids in this region alter such variables as the specificity and 
voltage-dependence of drug binding to the channels. Organic 
molecules are now being designed to interact with specific 
amino acid sequences in this key region of a number of ion 
channels (for review, see ref. 20). This structural approach to 
drug development offers exciting prospects for new therapies 
to treat diseases in which ion channels play a pathogenic role. 
In view of the central role of Ca 2+ in signal transduction, ew 
approaches to modifying Ca 2+ channel function seem espe- 
cially promising. 
P lasma Membrane  Ca z+ Channels  
The plasma membrane Ca 2÷ channels provide the major 
pathways for Ca 2+ entry into myocardial and most smooth 
muscle cells (for review see ref. 8 and 21-26). The major 
subunits, called alphal, arc a single large protein that contains 
four covalently inked domains (Fig. 2 and 3). However, not all 
members of this family respond in the same way to a change in 
membrane potential. Whereas membrane depolarization 
opens a pore in most Ca 2+ channels, in the case of the skeletal 
muscle protein the most important effect of depolarization is to 
initiate a conformational change that removes a "plug" that, in 
the muscle at rest, occludes the pore of an adjacent intracel- 
lular Ca 2+ release channel. Thus, even though Ca 2+ entry 
through the skeletal muscle plasma membrane Ca 2+ channel is 
too slow to provide an effective signal for excitation- 
contraction coupling, by opening intracellular Ca 2+ release 
channels this protein still plays a central role in Ca 2+ signal 
transduction. 
From a clinical standpoint, the most important members of 
this family are the L-type Ca 2+ channels (Table 3), which bind 
the familiar classes of Ca 2+ channel blockers (dihydropyridines 
such as nifedipine, phenylalkylamines such as verapamil, and 
benzothiazepines such as diltiazem). Closely related is the 
voltage sensor of skeletal muscle, which is also an L-type Ca 2+ 
channel. Other classes of plasma membrane Ca 2+ channels are 
referred to as T, N, P, Q and R (8,27) (Table 3). Complete 
structural information is not available for all members of this 
family of Ca 2+ channels, but as far as is now known, these 
membrane proteins are homologous both to each other and to 
the extended family of plasma membrane ion channel proteins 
listed in Table 2 (14,27,28). 
L-type calcium channels. The most abundant of the plasma 
membrane Ca 2+ channels in skeletal and cardiac muscle cells 
are the L-type channels which, as discussed earlier, play a key 
role in the intracellular Ca 2÷ cycle by opening the intracellular 
Ca 2+ release channels. Ca 2+ entry through the L-type Ca 2+ 
channels in the working cells of the atria and ventricles 
contributes to the plateau of the cardiac action potential as 
well as providing the Ca 2÷ that opens the intracellular Ca 2+ 
channels. In the SA node, Ca e* entry through L-type Ca 2÷ 
Table 3. Plasma Membrane Ca > Channels 
Channel Subtype Proposed Function 
Voltage-gated Ca 2+ channels 
L-type Ca 2÷ channels 
T-type Ca 2+ channels 
N-type Ca 2+ channels 
P-type Ca 2+ channels 
Q-type Ca 2+ channels 
R-type Ca 2+ channels 
Receptor-operated Ca 2+ channels 
Second messenger-operated Ca 2+ 
channels 
Skeletal excitation-contraction 
coupling; cardiac excitation- 
contraction coupling; cardiac 
pacemaker activity; cardiac 
atrioventricular conduction; 
transmitter r lease from endocrine 
cells 
Growth regulation; cardiac pacemaker 
activity 
Transmitter r lease from neurons 
Transmitter r lease from neurons and 
endocrine c lls 
Transmitter r lease from neuronal 
cells 
Transmitter r lease from neuronal 
cells 
Smooth muscle xcitation-contraction 
coupling; responses to stimuli in 
nonmotile c lls 
Responses to stimuli in nonmotile 
cells 
Ca 2+ = calcium ion. 
channels contributes to pacemaker activity, whereas members 
of this class of Ca 2+ channels in the AV node are essential for 
AV conduction. In smooth muscle, other L-type Ca 2+ channels 
participate in the extracellular Ca 2+ cycle by controlling the 
Ca 2+ entry that binds to and so directly activates the contrac- 
tile apparatus. L-type Ca 2+ channels are also found in endo- 
crine cells, where they regulate the Ca > entry responsible for 
excitation-secretion c upling, and in some neurons, where they 
control transmitter release. As noted earlier, it is the L-type 
Ca 2+ channels whose openings are inhibited by the familiar 
classes of clinically available Ca 2÷ channel blockers. 
T-type Ca z+ channels. The T-type Ca 2+ channels are 
found in a variety of tissues, including the heart and vascular 
smooth muscle. Like most L-type Ca 2÷ channels, T-type Ca 2+ 
channels are opened by membrane depolarization; however, 
studies of single-channel openings using patch clamp methods 
have shown several differences between the gating of L- and 
T-type Ca 2+ channels. One of these is the more rapid inacti- 
vation of the T-type than of the L-type Ca 2+ channels, which 
means that once the membrane is depolarized, the T-type 
Ca 2+ channels close and become refractory (inactivate) more 
quickly. This feature is responsible for the transient openings 
of the T-type Ca 2+ channels, and thus their name (T = 
transient, L = long-lasting). 
The threshold of the T-type Ca 2+ channels is lower than 
that of the L-type channels, which allows the former to be 
opened by smaller depolarizations than are needed to open the 
L-type Ca 2+ channels. Because their low threshold allows 
depolarization to begin when membrane potential has deviated 
only slightly from the resting potential, this property is well 
suited for the participation of T-type Ca 2+ channels in pace- 
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maker activity (29,30). The relatively high ratio of T-type Ca 2+ 
to L-type channels in the rabbit SA node (31) is also consistent 
with a role for the former in pacemaker activity. The impor- 
tance of the depolarizing current carried by T-type Ca 2+ 
channels in generating the upstroke of the action potential is 
less clear in the working cells of the atria and ventricles, where 
large inward currents are carried by more abundant and more 
rapidly opening Na + channels (see later). 
The distribution of L-type and T-type Ca 2+ channels is 
quite different in various types of cardiac muscle. The highest 
density of T-type Ca 2+ channels is found in cells, like nodal 
and embryonic ardiac myocytes, that lack a prominent trans- 
verse tubular system, whereas the ratio of L-type to T-type 
Ca 2+ channels is much higher in cells containing these struc- 
tures (32). The transverse tubules, which facilitate transmission 
of the depolarizing signal generated by an action potential into 
large cardiac myocytes that are specialized for contraction (1), 
are rich in the specialized junctions that provide the functional 
link between the plasma membrane Ca 2+ channels and the 
intracellular Ca 2+ release channels. The low density of T-type 
Ca 2+ channels in these structures therefore suggests that these 
channels do not play a primary role in excitation-contraction 
coupling. The finding that dihydropyridine Ca 2+ channel 
blockers, which inhibit L-type but not T-type Ca 2+ channels 
(32), prevent Ca 2+ release from the sarcoplasmic reticulum 
(33) also supports the view that the heart's T-type Ca 2+ 
channels play little role in cardiac excitation-contraction c u- 
pling. Further evidence that T-type Ca 2+ channels are not 
important for cardiac excitation-contraction c upling is their 
very low density in cardiac myocytes that are specialized for 
contraction. In the guinea pig heart, they are <10% of the 
density of the L-type Ca 2+ channels and 1% of that of Na + 
channels (34). However, in smooth muscle cells that lack 
abundant Na + channels, the T-type Ca 2+ channels can play an 
important role in activating contraction. 
The finding that the depolarizing current carried by the 
T-type Ca 2+ channels in guinea pig ventricular myocytes is 
concurrent with the much larger Na + current during the 
upstroke of the cardiac action potential (33) argues against an 
important role for the T-type Ca 2+ channels in generating the 
action potential upstroke. Unlike the brief depolarizing cur- 
rent carried by the T-type CaZ+-channels, which is almost 
entirely "buried" in the much larger Na + currents, the currents 
carried by the L-type Ca 2+ channels are more long-lasting. For 
this reason, although L-type Ca 2+ channels play only a minor 
role in the initial depolarizing current during the action 
potential upstroke in cells that contain large numbers of Na + 
channels, they make an important contribution to the slow 
inward Ca 2+ current hat occurs later, during the plateau of 
the action potential. 
The data just reviewed suggest that the T-type Ca 2+ 
channels in the heart are not of primary importance ither as 
charge carriers or as mediators of excitation-contraction c u- 
pling, and so play a quite different role in signal transduction 
than do the L-type Ca 2+ channels. Several ines of evidence 
indicate that the cardiac T-type Ca 2+ channels participate in 
signal transduction pathways that regulate cell growth and 
proliferation. For example, T-type Ca 2÷ channels are abun- 
dant in the fetal heart (35), and the densities of T- and L-type 
Ca 2+ channels are regulated differently during maturation, 
when the rate of growth slows markedly. Whereas L-type 
channel density remains fairly constant throughout early post- 
natal development, the number of T-type channels is greatest 
during periods of rapid growth, decreasing after growth ceases 
in the adult (36-40). Evidence for a growth-promoting effect 
of T-type Ca 2+ channel activation is found in reports that 
expression of this class of Ca 2+ channels increases when 
growth factors impinge on the heart; for example, when atrial 
myocytes are stimulated by growth hormone (41), and in 
hypertrophied myocytes isolated from both the pressure- 
overloaded left ventricle (42) and a genetic cardiomyopathy 
(43). Ca 2+ influx through channels whose threshold resembles 
that of T-type Ca 2+ channels has also been implicated in the 
proliferative response mediated by platelet-derived growth 
factor (44). The finding that Ca 2+ entry through T-type Ca 2+ 
channels is enhanced by endothelin-1, which induces myocar- 
dial hypertrophy and the expression of muscle specific genes 
(45), is also consistent with a role for these channels in 
regulating protein synthesis. Further evidence that activation 
of T-type Ca 2+ channels promotes cell growth is provided by 
recent evidence (46) that a specific blocker of these channels 
has an antiproliferative effect on damaged blood vessels. 
A clue as to how T-type Ca > channels might play a role in 
growth-regulating si nal cascades i found in a report (47) that 
these channels can be activated by diacylgylcerol, an intracel- 
lular signalling molecule that is released by phospholipase C.
The latter is a lipolytic enzyme that plays a prominent role in 
the regulation of protein synthesis and cell proliferation. The 
finding that phorbol esters, which mimic the growth-promoting 
effects of diacylgylcerol, also activate cardiac T-type Ca 2+ 
channels (47) provides additional evidence that these channels 
regulate cell growth. Furthermore, angiotensin II, an extracel- 
lular messenger that, when bound to AT 1 receptors, initiates a 
growth response that is mediated in part by diacylglycerol (48), 
also increases the opening of T-type Ca 2- channels in adrenal 
cells (49). Conversely, stimulation of AT 2 receptors--which, 
when bound to angiotensin II, have been reported to inhibit 
growth (50)--decreases the current carried by T-type Ca 2+ 
channels (51). Similarly, atrial natriuretic peptide, which inhib- 
its adrenal T-type Ca 2+ channels, blocks aldosterone secretion 
(52). Further evidence that Ca 2+ entry through T-type Ca e+ 
channels can stimulate protein synthesis is suggested by a 
report hat tetrandrine, an antihypertensive plant alkaloid that 
blocks T-type Ca 2+ channels, inhibits steroidogenesis by adre- 
nal cells (53), and that mibefradil (Ro 40-5967), another Ca 2+ 
channel blocker that under physiologic onditions is selective 
for T-type Ca 2+ channels, inhibits neointima formation after 
vascular injury (46). 
The availability of selective T-type Ca 2+ channel blockers is 
helping to define other physiologic roles of these ion channels 
in the cardiovascular system. One such drug, U-88779E, has a 
neuroprotective effect after cerebral ischemia (54). Vasodila- 
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tor (55,56) and antihypertensive ffects (57,58) seen after 
administration of the T-type Ca 2+ channel blocker mibefradil 
indicate that the Ca 2+ that enters arteriolar smooth muscle 
through T-type Ca 2+ channels helps to maintain tone in these 
resistance vessels. In the heart, as expected of a T-type Ca 2+ 
channel blocker, mibefradil inhibits the sinus pacemaker but 
has neither a significant inhibitory effect on AV node conduc- 
tion (59) nor a negative inotropic effect (59-62). Mibefradil 
has also been reported (63) to stimulate release of endothelial- 
derived relaxing factor. Whereas mibefradil can block L-type 
Ca 2+ channels in partially depolarized cells (64), this effect is 
attenuated at the normal resting potential, so that in the heart 
under physiologic conditions this drug is probably specific for 
T-type Ca 2+ channels, which are blocked at all levels of 
membrane potential (57). 
Although much remains to be learned about the pathophys- 
iologie role of T-type Ca 2+ channels, selective blockade of 
these channels holds promise for new advances in the treat- 
ment of cardiovascular disease. Furthermore, although details 
as to differences between the L-type and T-type Ca 2+ channels 
are still emerging, it is already clear that the extensive clinical 
experience with the familiar L-type Ca 2+ channel blockers 
cannot be extrapolated to new drugs that selectively block 
T-type channels. This follows because, even though blockade 
of either class of Ca 2+ channels can be expected to inhibit the 
entry of messenger Ca 2+ into cells, this Ca 2+ participates in 
different signal transduction systems. This action reflects the 
fact that the effects of the Ca 2+ that enters cells are quite 
localized (4,6), due in large part to the buffering effect of the 
many intracellular Ca r+ binding proteins (65). 
Conc lus ions  
This review of the Ca 2~ channels that regulate Ca 2+ flux 
into the cytosol illustrates how variations both between and 
among members of different families of channel proteins has 
contributed to the remarkable signaling diversity seen in the 
cardiovascular system. Duplication and divergence of genes 
that encoded common ancestral proteins has provided a daz- 
zling array of specialized proteins able to mediate the many 
different signal transduction pathways that utilize messenger 
Ca z+ to modify cell function. Understanding the roles of these 
specializations is of considerable potential clinical value be- 
cause several of these regulatory proteins, notably the plasma 
membrane Ca 2+ channels, can be modified selectively by 
drugs. New knowledge of the structure and biology of the Ca 2+ 
channel proteins could allow the design of drug molecules able 
to modify specific signal transduction cascades, thereby pro- 
viding new agents for the treatment of cardiovascular disease. 
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